Monday, December 9, 2013
Monday, November 18, 2013
Monday, October 28, 2013
Monday, October 21, 2013
Monday, October 14, 2013
Thursday, October 10, 2013
Wednesday, October 9, 2013
Tuesday, October 8, 2013
Monday, October 7, 2013
Wednesday, October 2, 2013
Tuesday, October 1, 2013
Friday, September 27, 2013
Wednesday, September 18, 2013
Monday, September 9, 2013
Friday, September 6, 2013
Thursday, September 5, 2013
Thursday, August 29, 2013
Monday, August 19, 2013
Monday, August 12, 2013
Friday, August 9, 2013
Monday, August 5, 2013
Friday, August 2, 2013
Wednesday, July 31, 2013
Tuesday, July 30, 2013
Monday, July 29, 2013
Thursday, July 25, 2013
Tuesday, July 23, 2013
Monday, July 22, 2013
Friday, July 19, 2013
Tuesday, July 16, 2013
Monday, July 15, 2013
Friday, July 12, 2013
Thursday, July 11, 2013
Monday, July 8, 2013
Wednesday, July 3, 2013
Friday, June 28, 2013
Thursday, June 27, 2013
Tuesday, June 25, 2013
Monday, June 24, 2013
Thursday, June 20, 2013
Wednesday, June 19, 2013
Sunday, June 16, 2013
Wednesday, June 12, 2013
Monday, June 10, 2013
Friday, June 7, 2013
Thursday, June 6, 2013
Friday, May 31, 2013
Wednesday, May 29, 2013
Tuesday, May 21, 2013
Wednesday, May 15, 2013
Tuesday, May 14, 2013
Monday, May 13, 2013
Friday, May 10, 2013
Tuesday, May 7, 2013
Monday, May 6, 2013
Friday, May 3, 2013
Thursday, May 2, 2013
Wednesday, May 1, 2013
Monday, April 29, 2013
Thursday, April 25, 2013
Tuesday, April 23, 2013
Monday, April 22, 2013
Thursday, April 18, 2013
Wednesday, April 17, 2013
Friday, April 12, 2013
Thursday, April 11, 2013
Wednesday, April 10, 2013
Monday, April 8, 2013
Wednesday, April 3, 2013
Tuesday, April 2, 2013
Monday, April 1, 2013
Friday, March 29, 2013
Wednesday, March 27, 2013
Tuesday, March 26, 2013
Monday, March 25, 2013
Friday, March 22, 2013
Thursday, March 21, 2013
Obstetrics & Gynecology - Popular Press News Article | Antidepressants for pregnant moms don't affect infants' growth |4526843
Obstetrics & Gynecology - Popular Press News Article | Antidepressants for pregnant moms don't affect infants' growth |4526843
Selective serotonin reuptake inhibitor (SSRI) antidepressants taken by a woman during pregnancy do not impact her infant's growth over the first year, reports a new study from a Northwestern Medicine scientist. The new study showed infants born to mothers who took SSRIs during pregnancy had a similar weight, length and head circumference over the first year as infants born to non–depressed women who did not take antidepressants. The infants whose mothers took antidepressants were shorter at birth, but the difference disappeared by two weeks of age.
Selective serotonin reuptake inhibitor (SSRI) antidepressants taken by a woman during pregnancy do not impact her infant's growth over the first year, reports a new study from a Northwestern Medicine scientist. The new study showed infants born to mothers who took SSRIs during pregnancy had a similar weight, length and head circumference over the first year as infants born to non–depressed women who did not take antidepressants. The infants whose mothers took antidepressants were shorter at birth, but the difference disappeared by two weeks of age.
Wednesday, March 20, 2013
Monday, March 18, 2013
Friday, March 15, 2013
Thursday, March 14, 2013
Obstetrics & Gynecology - Repro Endo - Infertility News Article | Impact of superovulation for women with endometriosis |4483060
Obstetrics & Gynecology - Repro Endo - Infertility News Article | Impact of superovulation for women with endometriosis |4483060
Kavoussi SK – Superovulation (SO)/Intrauterine insemination (IUI) has been used as a treatment approach for endometriosis–associated infertility. The existing medical literature regarding SO in endometriosis patients is composed of heterogeneous studies that differ in terms of study design, SO protocols, the addition of IUI, and comparison groups. There is a need for more well–designed studies to further investigate the efficacy of SO in women with endometriosis–associated infertility. Although in vitro fertilization (IVF) is most effective and is significantly superior to other treatments in endometriosis patients, most of the existing studies suggest some benefit of SO/IUI in infertility patients with early–stage disease. Therefore, SO/IUI is a reasonable early fertility treatment option for women with endometriosis who desire a short trial of potentially more cost–effective treatment options prior to pursuing an IVF cycle and those for whom IVF is not a feasible or desirable option. It appears that gonadotropins are most effective for SO in this patient population even though more head–to–head comparisons are needed.
Kavoussi SK – Superovulation (SO)/Intrauterine insemination (IUI) has been used as a treatment approach for endometriosis–associated infertility. The existing medical literature regarding SO in endometriosis patients is composed of heterogeneous studies that differ in terms of study design, SO protocols, the addition of IUI, and comparison groups. There is a need for more well–designed studies to further investigate the efficacy of SO in women with endometriosis–associated infertility. Although in vitro fertilization (IVF) is most effective and is significantly superior to other treatments in endometriosis patients, most of the existing studies suggest some benefit of SO/IUI in infertility patients with early–stage disease. Therefore, SO/IUI is a reasonable early fertility treatment option for women with endometriosis who desire a short trial of potentially more cost–effective treatment options prior to pursuing an IVF cycle and those for whom IVF is not a feasible or desirable option. It appears that gonadotropins are most effective for SO in this patient population even though more head–to–head comparisons are needed.
Obstetrics & Gynecology News Article | Noninvasive screening tools for Down syndrome: a review |4509955
Obstetrics & Gynecology News Article | Noninvasive screening tools for Down syndrome: a review |4509955
Smith M and Visootsak J.– This review summarizes all currently available noninvasive diagnostic techniques for the detection of Down syndrome.Down syndrome is the leading cause of prenatal chromosome abnormalities, accounting for 53% of all reported chromosome conditions. Testing strategies, guidelines, and screening options have expanded from their conception in the 1970s, and now include such options as anatomical ultrasound, maternal serum screening, and noninvasive prenatal testing. By understanding fully each technology and the possible alternatives, the physician will be able to provide their patients with all the information necessary to make an informed decision regarding their medical management.
Smith M and Visootsak J.– This review summarizes all currently available noninvasive diagnostic techniques for the detection of Down syndrome.Down syndrome is the leading cause of prenatal chromosome abnormalities, accounting for 53% of all reported chromosome conditions. Testing strategies, guidelines, and screening options have expanded from their conception in the 1970s, and now include such options as anatomical ultrasound, maternal serum screening, and noninvasive prenatal testing. By understanding fully each technology and the possible alternatives, the physician will be able to provide their patients with all the information necessary to make an informed decision regarding their medical management.
Obstetrics & Gynecology - Popular Press News Article | Omega-3 DHA may prevent earliest preemies |4507708
Obstetrics & Gynecology - Popular Press News Article | Omega-3 DHA may prevent earliest preemies |4507708
For pregnant women, supplements of an omega–3 fatty acid called Docosahexaenoic acid (DHA) may help to reduce the likelihood of giving birth very prematurely, according to a new study. The results add to evidence that omega–3 fatty acid supplements make pregnancy last a little longer, which means more development time for babies before birth, less hospital time after birth and a better long–term health outlook.
For pregnant women, supplements of an omega–3 fatty acid called Docosahexaenoic acid (DHA) may help to reduce the likelihood of giving birth very prematurely, according to a new study. The results add to evidence that omega–3 fatty acid supplements make pregnancy last a little longer, which means more development time for babies before birth, less hospital time after birth and a better long–term health outlook.
Wednesday, March 13, 2013
Obstetrics & Gynecology - Repro Endo - Infertility News Article | Disposition of abandoned embryos: a committee opinion |4497572
Obstetrics & Gynecology - Repro Endo - Infertility News Article | Disposition of abandoned embryos: a committee opinion |4497572
Programs should create and enforce written policies on the designation, retention, and disposal of abandoned embryos. In the absence of program–specific policies, it is ethically acceptable for a program or facility to consider embryos to have been abandoned if at least 5 years have passed since contact with an individual or couple, diligent efforts have been made to contact the individual or couple, and no written instructions from the couple exist concerning disposition. In such cases, programs may dispose of the embryos by removal from storage and thawing without transfer, though in no case should embryos deemed abandoned be donated to other couples or be used in research.
Programs should create and enforce written policies on the designation, retention, and disposal of abandoned embryos. In the absence of program–specific policies, it is ethically acceptable for a program or facility to consider embryos to have been abandoned if at least 5 years have passed since contact with an individual or couple, diligent efforts have been made to contact the individual or couple, and no written instructions from the couple exist concerning disposition. In such cases, programs may dispose of the embryos by removal from storage and thawing without transfer, though in no case should embryos deemed abandoned be donated to other couples or be used in research.
Tuesday, March 12, 2013
Endocrinology - Popular Press News Article | Interval training can boost exercise effects while reducing a workouts length |4506305
Endocrinology - Popular Press News Article | Interval training can boost exercise effects while reducing a workouts length |4506305
Want to cut the length of your workout while maintaining or even increasing the benefits? Try interval training, a type of cardiovascular workout in which you alternate bursts of peppier exercise with slower–paced recovery periods. Intervals make you work more efficiently: Your overall intensity is greater, so the length of your workout can be cut by about 20 percent. Plus, a growing body of evidence suggests that this approach yields health benefits comparable or superior to traditional exercise. Interval training has been linked to improved levels of HDL (good) cholesterol.
Want to cut the length of your workout while maintaining or even increasing the benefits? Try interval training, a type of cardiovascular workout in which you alternate bursts of peppier exercise with slower–paced recovery periods. Intervals make you work more efficiently: Your overall intensity is greater, so the length of your workout can be cut by about 20 percent. Plus, a growing body of evidence suggests that this approach yields health benefits comparable or superior to traditional exercise. Interval training has been linked to improved levels of HDL (good) cholesterol.
Monday, March 11, 2013
Friday, March 8, 2013
Obstetrics & Gynecology News Article | Vitamin D status in Chinese pregnant women and their newborns in Beijing and their relationships to birth size |4491874
Obstetrics & Gynecology News Article | Vitamin D status in Chinese pregnant women and their newborns in Beijing and their relationships to birth size |4491874
Newborns of mothers with severe vitamin D deficiency had lower birth length and birth weight.
The head circumference and birth weight were lower in vitamin D–deficient newborns.
Newborns of mothers with severe vitamin D deficiency had lower birth length and birth weight.
Endocrinology - Popular Press News Article | Exercise shields children from stress, research indicates |4497828
Endocrinology - Popular Press News Article | Exercise shields children from stress, research indicates |4497828
Exercise may play a key role in helping children cope with stressful situations, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). When they are exposed to everyday stressors, the study found sedentary children had surges of cortisol – a hormone linked to stress. The most active children had little or no increase in their cortisol levels in similar situations. The findings suggest physical activity plays a role in mental health by buffering children from the effects of daily stressors, such as public speaking.
Exercise may play a key role in helping children cope with stressful situations, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). When they are exposed to everyday stressors, the study found sedentary children had surges of cortisol – a hormone linked to stress. The most active children had little or no increase in their cortisol levels in similar situations. The findings suggest physical activity plays a role in mental health by buffering children from the effects of daily stressors, such as public speaking.
Endocrinology - Popular Press News Article | Up to half of gestational diabetes patients will develop type 2 diabetes, study finds |4497827
Endocrinology - Popular Press News Article | Up to half of gestational diabetes patients will develop type 2 diabetes, study finds |4497827
Women who were diagnosed with gestational diabetes during pregnancy face a significantly higher risk of developing Type 2 diabetes in the future, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Women who were diagnosed with gestational diabetes during pregnancy face a significantly higher risk of developing Type 2 diabetes in the future, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Internal Medicine News Article | Unlocking mysteries of the mind |4498220
Internal Medicine News Article | Unlocking mysteries of the mind |4498220
You have a brain with billions of neurons. You have thoughts, and you do things because of those thoughts. But how do tiny cells translate into thoughts and actions? The Brain Activity Map initiative is seeking answers to that question. As described in a proposal published online Thursday in the journal Science Express, a group of prominent researchers is proposing a large–scale effort to create new tools to map the human brain in unprecedented detail. This could lead to treatments for brain disorders such as epilepsy, autism, dementia, depression and schizophrenia, as well as ways to restore movement in paralyzed patients. Within 5 years, it should be possible to monitor and control tens of thousands of neurons, scientists say.
You have a brain with billions of neurons. You have thoughts, and you do things because of those thoughts. But how do tiny cells translate into thoughts and actions? The Brain Activity Map initiative is seeking answers to that question. As described in a proposal published online Thursday in the journal Science Express, a group of prominent researchers is proposing a large–scale effort to create new tools to map the human brain in unprecedented detail. This could lead to treatments for brain disorders such as epilepsy, autism, dementia, depression and schizophrenia, as well as ways to restore movement in paralyzed patients. Within 5 years, it should be possible to monitor and control tens of thousands of neurons, scientists say.
Thursday, March 7, 2013
Reproductive Endocrinology News Article | Comparison of Detection of Normal Puberty in Girls by a Hormonal Sleep Test and a Gonadotropin-Releasing Hormone Agonist Test |4486853
The objective of the study was to determine the normal relationship of pubertal hormone responses to sleep and to GnRH agonist (GnRHag) challenge across the female pubertal transition. These data suggest that sleep–related pubertal hormone levels critical for puberty are normally reflected in the responses to GnRHag testing across the normal female pubertal transition. Inconsistencies between clinical and hormonal staging may arise from peripubertal cyclicity of neuroendocrine function and from excess adiposity.
Read more:Reproductive Endocrinology News Article | Comparison of Detection of Normal Puberty in Girls by a Hormonal Sleep Test and a Gonadotropin-Releasing Hormone Agonist Test |4486853
Read more:Reproductive Endocrinology News Article | Comparison of Detection of Normal Puberty in Girls by a Hormonal Sleep Test and a Gonadotropin-Releasing Hormone Agonist Test |4486853
Subscribe to:
Posts (Atom)
Posts
